Biocomposite for Prolonged Release of Water-Soluble Drugs
Pharmaceutics · 14.06.2023 · 15 (6) · 1722
DOI: 10.3390/pharmaceutics15061722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 14.06.2023. Verfasst von Lyghia M A Meirelles und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior- Brazil (CAPES), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brazil (CAPES).
Abstract (Originalsprache)
This study aimed to develop a prolonged-release system based on palygorskite and chitosan, which are natural ingredients widely available, affordable, and accessible. The chosen model drug was ethambutol (ETB), a tuberculostatic drug with high aqueous solubility and hygroscopicity, which is incompatible with other drugs used in tuberculosis therapy. The composites loaded with ETB were obtained using different proportions of palygorskite and chitosan through the spray drying technique. The main physicochemical properties of the microparticles were determined using XRD, FTIR, thermal analysis, and SEM. Additionally, the release profile and biocompatibility of the microparticles were evaluated. As a result, the chitosan–palygorskite composites loaded with the model drug appeared as spherical microparticles. The drug underwent amorphization within the microparticles, with an encapsulation efficiency greater than 84%. Furthermore, the microparticles exhibited prolonged release, particularly after the addition of palygorskite. They demonstrated biocompatibility in an in vitro model, and their release profile was influenced by the proportion of inputs in the formulation. Therefore, incorporating ETB into this system offers improved stability for the administered product in the initial tuberculosis pharmacotherapy dose, minimizing its contact with other tuberculostatic agents in the treatment, as well as reducing its hygroscopicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.
- Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Campus de Cartuja s/n, University of Granada, 18071 Granada, Spain.
- Immunology Laboratory, Pharmacy Faculty, Federal University of Rio Grande do Norte, Natal 59010-180, Brazil.
- Department of Pharmaceutic Science, University of Perugia, 06123 Perugia, Italy.
- Andalusian Institute of Earth Sciences, CSIC-University of Granada, Av. de Las Palmeras 4, 18100 Armilla, Spain.
ORCID-Profile: Raquel de Melo Barbosa, Luana Perioli, César Viseras, Fernanda Nervo Raffin
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior- Brazil (CAPES)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brazil (CAPES)
Zitieren
APA
Meirelles, L. M. A., de Melo Barbosa, R., de Almeida Júnior, R. F., Machado, P. R. L., Perioli, L., Viseras, C., & Raffin, F. N. (2023). Biocomposite for Prolonged Release of Water-Soluble Drugs. Pharmaceutics, 15(6), 1722. https://doi.org/10.3390/pharmaceutics15061722
Vancouver
Meirelles LMA, de Melo Barbosa R, de Almeida Júnior RF, Machado PRL, Perioli L, Viseras C, et al. Biocomposite for Prolonged Release of Water-Soluble Drugs. Pharmaceutics. 2023;15(6):1722. doi:10.3390/pharmaceutics15061722
BibTeX
@article{Meirelles2023,
author = {Meirelles, Lyghia M A and de Melo Barbosa, Raquel and de Almeida Júnior, Renato Ferreira and Machado, Paula Renata Lima and Perioli, Luana and Viseras, César and Raffin, Fernanda Nervo},
title = {Biocomposite for Prolonged Release of Water-Soluble Drugs},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {6},
pages = {1722},
doi = {10.3390/pharmaceutics15061722}
}
EUVIMED